| Michael Epstein, MD | |
|
2514 E Dupont Rd Ste 100, Fort Wayne, IN 46825-1619 | |
| (260) 484-8830 | |
| (260) 483-1911 |
| Full Name | Michael Epstein |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 39 Years |
| Location | 2514 E Dupont Rd Ste 100, Fort Wayne, Indiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437151347 | NPI | - | NPPES |
| 3045752 | Medicaid | OH | |
| 200360320 | Medicaid | IN | |
| 000000213360 | Other | IN | ANTHEM |
| 000000693341 | Other | IN | ANTHEM |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 01055186A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bluffton Regional Medical Center | Bluffton, IN | Hospital |
| Lutheran Hospital Of Indiana | Fort wayne, IN | Hospital |
| Dupont Hospital Llc | Fort wayne, IN | Hospital |
| Parkview Regional Medical Center | Fort wayne, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fort Wayne Medical Oncology And Hematology Inc | 2961394440 | 27 |
News Archive
A new study has made a major new discovery towards finding the cause of multiple sclerosis (MS), potentially paving the way for research to investigate new treatments.
Vical Incorporated announced today the receipt of approximately $12.1 million in production orders for multiple clinical lots of DNA vaccines against HIV for the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases, under a subcontract managed by SAIC-Frederick, Inc.
Low-income Medicare beneficiaries who qualify for the $600 credit when they enroll in a Medicare-approved drug discount card will not have to worry that this help will be counted against them when they apply for Medicaid or other federal government benefit programs like housing and food stamps.
Dr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.
Research & Diagnostic Antibodies LLC (R&D Antibodies) announced today that it has received a notification stating that the European Patent Office intends to grant a patent for its monoclonal antibody-based immunoassays and apparatuses for measuring inducible nitric oxide synthase (iNOS) as a plasma biomarker for the early detection of the sepsis pathology.
› Verified 1 days ago
| Entity Name | Parkview Health System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932130952 PECOS PAC ID: 2163336967 Enrollment ID: O20031117000288 |
News Archive
A new study has made a major new discovery towards finding the cause of multiple sclerosis (MS), potentially paving the way for research to investigate new treatments.
Vical Incorporated announced today the receipt of approximately $12.1 million in production orders for multiple clinical lots of DNA vaccines against HIV for the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases, under a subcontract managed by SAIC-Frederick, Inc.
Low-income Medicare beneficiaries who qualify for the $600 credit when they enroll in a Medicare-approved drug discount card will not have to worry that this help will be counted against them when they apply for Medicaid or other federal government benefit programs like housing and food stamps.
Dr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.
Research & Diagnostic Antibodies LLC (R&D Antibodies) announced today that it has received a notification stating that the European Patent Office intends to grant a patent for its monoclonal antibody-based immunoassays and apparatuses for measuring inducible nitric oxide synthase (iNOS) as a plasma biomarker for the early detection of the sepsis pathology.
› Verified 1 days ago
| Entity Name | Fort Wayne Medical Oncology And Hematology Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376533158 PECOS PAC ID: 2961394440 Enrollment ID: O20040329000797 |
News Archive
A new study has made a major new discovery towards finding the cause of multiple sclerosis (MS), potentially paving the way for research to investigate new treatments.
Vical Incorporated announced today the receipt of approximately $12.1 million in production orders for multiple clinical lots of DNA vaccines against HIV for the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases, under a subcontract managed by SAIC-Frederick, Inc.
Low-income Medicare beneficiaries who qualify for the $600 credit when they enroll in a Medicare-approved drug discount card will not have to worry that this help will be counted against them when they apply for Medicaid or other federal government benefit programs like housing and food stamps.
Dr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.
Research & Diagnostic Antibodies LLC (R&D Antibodies) announced today that it has received a notification stating that the European Patent Office intends to grant a patent for its monoclonal antibody-based immunoassays and apparatuses for measuring inducible nitric oxide synthase (iNOS) as a plasma biomarker for the early detection of the sepsis pathology.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Epstein, MD 2514 E Dupont Rd Ste 100, Fort Wayne, IN 46825-1619 Ph: (260) 484-8830 | Michael Epstein, MD 2514 E Dupont Rd Ste 100, Fort Wayne, IN 46825-1619 Ph: (260) 484-8830 |
News Archive
A new study has made a major new discovery towards finding the cause of multiple sclerosis (MS), potentially paving the way for research to investigate new treatments.
Vical Incorporated announced today the receipt of approximately $12.1 million in production orders for multiple clinical lots of DNA vaccines against HIV for the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases, under a subcontract managed by SAIC-Frederick, Inc.
Low-income Medicare beneficiaries who qualify for the $600 credit when they enroll in a Medicare-approved drug discount card will not have to worry that this help will be counted against them when they apply for Medicaid or other federal government benefit programs like housing and food stamps.
Dr. Marc McKee, of McGill's Faculty of Dentistry and the Department of Anatomy and Cell Biology, is collaborating closely with Enobia Pharma Inc, a Quebec biotech company, to develop innovative treatments for serious genetic bone diseases. McKee's research looks into the reasons why calcium-phosphate mineral fails to crystallize properly to form strong bones and teeth.
Research & Diagnostic Antibodies LLC (R&D Antibodies) announced today that it has received a notification stating that the European Patent Office intends to grant a patent for its monoclonal antibody-based immunoassays and apparatuses for measuring inducible nitric oxide synthase (iNOS) as a plasma biomarker for the early detection of the sepsis pathology.
› Verified 1 days ago
Dr. Dustin M Thomas, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11108 Parkview Plaza Dr, Fort Wayne, IN 46845 Phone: 260-266-5700 Fax: 260-266-5910 | |
Ahmad Alhariri, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11109 Parkview Plaza Dr, Fort Wayne, IN 46845 Phone: 260-266-2020 | |
Dr. Anuradha G Bommakanti, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7950 W Jefferson Blvd, Fort Wayne, IN 46804 Phone: 260-435-7001 | |
Eileen Jill Ramos Muzzillo, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4402 E State Blvd, Fort Wayne, IN 46815 Phone: 260-425-5600 Fax: 260-425-5605 | |
John T Ducker, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 7836 W Jefferson Blvd, Suite 101, Fort Wayne, IN 46804 Phone: 260-494-3484 Fax: 260-969-0188 | |
Mr. Kenneth A Smith, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1234 East Dupont Road, Suite 5, Fort Wayne, IN 46825 Phone: 260-489-1666 Fax: 260-489-3255 | |
Dr. Carl Marc Williams, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 11104 Parkview Circle Dr, Fort Wayne, IN 46845 Phone: 260-373-9700 Fax: 260-373-9740 |